Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission
Pursuing accelerated approval for bitopertin in EPP with protoporphyrin IX (PPIX) reduction as the surrogate endpointPlanning to submit NDA under ...
Healthline10d
8 Steps to Take Before Starting Hepatitis C Treatment
If you’ve recently received a hepatitis C diagnosis, there are several ways you can contribute to the success of your treatment. For example, you can stay on top of your health, communicate with ...
Disc Medicine announces feedback from Type C meeting with FDA
Disc Medicine (IRON) announced positive feedback from its Type C meeting with the U.S. Food and Drug Administration, FDA, to discuss the APOLLO ...